Skip to main content

Advertisement

New reviewer recruitment

New Content Item
Cancer Cell International invites you to join our team of reviewers. For consideration, please send your CV to aoife.buckley@biomedcentral.com.

Aims and scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.

Articles

Trending articles

Click here to view which articles have been shared the most in the last month!

Editor-in-Chief

Domenico Coppola, Moffitt Cancer Center and Florida Digestive Health Specialists, USA

Latest Tweets

Spotlight: Associate Editor

Andy Tao Yin LauAndy Tao Yin Lau

After obtaining his PhD degree (Molecular Biology) at the University of Hong Kong, Dr. Andy Tao Yin Lau joined the University of Minnesota (USA) as a postdoctoral fellow on Cancer and Epigenetics Research. Since 2011, he has been working as a Principal Investigator and established the Laboratory of Cancer Biology and Epigenetics at Shantou University Medical College (P. R. China). Dr. Lau’s research team studies the molecular basis of cancers by using “OMICS” approaches. For example, he has applied proteomic-based platform to study the proteome and epiproteome responses of carcinogen-exposed lung cells/anticancer drug-treated lung cancer cells and the identification of novel biomarker signatures. Moreover, he is interested in functional characterization of novel protein post-translational modifications and their relationship in human diseases including cancers.

Spotlight: Editorial Board

Koraljka Gall TrošeljKoraljka Gall Trošelj

Dr. Koraljka Gall Trošelj earned her MD degree at the University of Zagreb (Croatia), from where she received both a Masters and PhD degree in biomedicine – molecular oncology. She is a Fulbright Scholar who spent two years in the US at the Weill Cornell Medical School in New York City. Dr. Gall Trošelj is currently the head of the Laboratory for Epigenomics in the Division of Molecular Medicine at the Rudjer Boskovic Institute, Zagreb, Croatia. Dr. Gall Troselj is particularly interested in modulation of the epigenome by natural compounds, especially curcumin, in the context of chemoprevention. She has developed a fruitful collaboration with Croatian clinicians, especially oncologists, head and neck surgeons and pathologists. Her current national research project, funded by the Croatian Science Foundation (NRF2 at the crossroads of epigenetic remodeling, metabolism and proliferation of cancer cells), is focused on discovering mechanisms of NRF2 and EZH2 interplay in a setting of various kinds of cellular stresses to which cancer cells are or may be exposed.

Advertisement

Annual Journal Metrics

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here

Advertisement